Original Research
Published on 04 Dec 2024
Adjuvant sorafenib for hepatocellular carcinoma after radiofrequency ablation versus radiofrequency ablation: analysis of its efficacy and safety
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
- 818 views